Chen H, Li L, Du Y
Front Pharmacol. 2023; 14:1115226.
PMID: 36937859
PMC: 10017497.
DOI: 10.3389/fphar.2023.1115226.
Wang H, Brey C, Wang Y, Gaugler R, Hashmi S
3 Biotech. 2023; 13(3):87.
PMID: 36816753
PMC: 9935763.
DOI: 10.1007/s13205-023-03502-5.
Xiong Q, Zhang Z, Yang Y, Xu Y, Zhou Y, Zhang S
J Clin Med. 2023; 12(1).
PMID: 36615000
PMC: 9821328.
DOI: 10.3390/jcm12010200.
Hu K, Ma C, Ma R, Zheng Q, Wang Y, Zhang N
Am J Cancer Res. 2022; 12(10):4468-4482.
PMID: 36381325
PMC: 9641401.
Lyu Y, Guan Y, Deliu L, Humphrey E, Frontera J, Yang Y
Genes Dev. 2022; .
PMID: 36008138
PMC: 9480852.
DOI: 10.1101/gad.349662.122.
VEGF-A controls the expression of its regulator of angiogenic functions, dopamine D2 receptor, on endothelial cells.
Sarkar C, Chakroborty D, Goswami S, Fan H, Mo X, Basu S
J Cell Sci. 2022; 135(11).
PMID: 35593650
PMC: 9234670.
DOI: 10.1242/jcs.259617.
KLF10 upregulates ACSM3 via the PI3K/Akt signaling pathway to inhibit the malignant progression of melanoma.
Zhao Z, Zhan Y, Jing L, Zhai H
Oncol Lett. 2022; 23(6):175.
PMID: 35497935
PMC: 9019859.
DOI: 10.3892/ol.2022.13295.
Exploring the Interaction between the SWI/SNF Chromatin Remodeling Complex and the Zinc Finger Factor CTCF.
Valletta M, Russo R, Baglivo I, Russo V, Ragucci S, Sandomenico A
Int J Mol Sci. 2020; 21(23).
PMID: 33255744
PMC: 7728349.
DOI: 10.3390/ijms21238950.
Two Sides of the Same Coin: The Roles of KLF6 in Physiology and Pathophysiology.
Syafruddin S, Mohtar M, Nazarie W, Low T
Biomolecules. 2020; 10(10).
PMID: 32998281
PMC: 7601070.
DOI: 10.3390/biom10101378.
Unraveling cancer lineage drivers in squamous cell carcinomas.
Guan Y, Wang G, Fails D, Nagarajan P, Ge Y
Pharmacol Ther. 2019; 206:107448.
PMID: 31836455
PMC: 6995404.
DOI: 10.1016/j.pharmthera.2019.107448.
Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.
Chaiprasert T, Armartmuntree N, Techasen A, Sakonsinsiri C, Pinlaor S, Ungarreevittaya P
Biomolecules. 2019; 9(7).
PMID: 31284679
PMC: 6681239.
DOI: 10.3390/biom9070263.
Overexpression of matrix metalloproteinase-9 in breast cancer cell lines remarkably increases the cell malignancy largely via activation of transforming growth factor beta/SMAD signalling.
Dong H, Diao H, Zhao Y, Xu H, Pei S, Gao J
Cell Prolif. 2019; 52(5):e12633.
PMID: 31264317
PMC: 6797518.
DOI: 10.1111/cpr.12633.
Matrix metalloproteinase-2, -9, and tissue inhibitor of MMP-2 gene polymorphisms in Taiwanese periodontitis patients.
Hsiao Y, Yang L, Chou Y, Ho Y, Lin Y, Ho K
J Dent Sci. 2019; 11(4):411-418.
PMID: 30895006
PMC: 6395246.
DOI: 10.1016/j.jds.2016.07.001.
THBS4 predicts poor outcomes and promotes proliferation and metastasis in gastric cancer.
Chen X, Huang Y, Wang Y, Wu Q, Hong S, Huang Z
J Physiol Biochem. 2019; 75(1):117-123.
PMID: 30746617
DOI: 10.1007/s13105-019-00665-9.
C2H2-Type Zinc Finger Proteins: Evolutionarily Old and New Partners of the Nuclear Hormone Receptors.
Mackeh R, Marr A, Fadda A, Kino T
Nucl Recept Signal. 2019; 15:1550762918801071.
PMID: 30718982
PMC: 6348741.
DOI: 10.1177/1550762918801071.
KLF10 as a Tumor Suppressor Gene and Its TGF-β Signaling.
Memon A, Lee W
Cancers (Basel). 2018; 10(6).
PMID: 29799499
PMC: 6025274.
DOI: 10.3390/cancers10060161.
Extracted metabolite from ABRIINW111 altered the gene expression in colon cancer.
Fatourachi P, Faramarziyan Azimi Maragheh B, Mohammadi S, Valipour B, Dehnad A, Nozad Charoudeh H
Gastroenterol Hepatol Bed Bench. 2018; 11(1):34-41.
PMID: 29564063
PMC: 5849116.
Krüpple-like-factor 4 Attenuates Lung Fibrosis via Inhibiting Epithelial-mesenchymal Transition.
Lin L, Han Q, Xiong Y, Li T, Liu Z, Xu H
Sci Rep. 2017; 7(1):15847.
PMID: 29158503
PMC: 5696468.
DOI: 10.1038/s41598-017-14602-7.
KLF2 in Regulation of NF-κB-Mediated Immune Cell Function and Inflammation.
Jha P, Das H
Int J Mol Sci. 2017; 18(11).
PMID: 29125549
PMC: 5713352.
DOI: 10.3390/ijms18112383.
The rs243865 polymorphism increases the risk of prostate cancer: A meta-analysis.
Liu K, Gu S, Liu X, Sun Q, Wang Y, Meng J
Oncotarget. 2017; 8(42):72933-72938.
PMID: 29069837
PMC: 5641180.
DOI: 10.18632/oncotarget.18014.